Education
About Us
Working with TipRanks
Follow Us
Circassia Pharmaceuticals (GB:NIOX)
:NIOX
RESEARCH TOOLSreports
See the Price Targets and Ratings of:
NIOX Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
0.5p
Hold
-99.30%
Downside
Reiterated
07/08/25
Circassia Pharmaceuticals demonstrates strong financial performance and positive technical trends, which are offset by concerns about high valuation and potential risks from recent corporate developments. Strategic initiatives and growth in key sectors support the stock's potential, but investors should be cautious of overvaluation.
Unknown AnalystBerenberg Bank
Not Ranked
Berenberg Bank
90p
Buy
26.76%
Upside
Reiterated
04/15/25
Unknown AnalystDeutsche Bank
Not Ranked
Deutsche Bank
90p
Buy
26.76%
Upside
Reiterated
04/15/25
Stifel Nicolaus
77p
Buy
8.45%
Upside
Reiterated
04/11/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
0.5p
Hold
-99.30%
Downside
Reiterated
07/08/25
Circassia Pharmaceuticals demonstrates strong financial performance and positive technical trends, which are offset by concerns about high valuation and potential risks from recent corporate developments. Strategic initiatives and growth in key sectors support the stock's potential, but investors should be cautious of overvaluation.
Unknown AnalystBerenberg Bank
Not Ranked
Berenberg Bank
90p
Buy
26.76%
Upside
Reiterated
04/15/25
Unknown AnalystDeutsche Bank
Not Ranked
Deutsche Bank
90p
Buy
26.76%
Upside
Reiterated
04/15/25
Stifel Nicolaus
77p
Buy
8.45%
Upside
Reiterated
04/11/25
Best Analysts Covering Circassia Pharmaceuticals
1 Month
xxx
Success Rate
1/5 ratings generated profit
Average Return
-2.88%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 20.00% of your transactions generating a profit, with an average return of -2.88% per trade.
3 Months
xxx
Success Rate
1/5 ratings generated profit
Average Return
+0.46%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 20.00% of your transactions generating a profit, with an average return of +0.46% per trade.
1 Year
Success Rate
4/5 ratings generated profit
Average Return
+11.78%
reiterated a buy rating 3 months ago
Copying James Orsborne's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +11.78% per trade.
2 Years
xxx
Success Rate
4/5 ratings generated profit
Average Return
+11.36%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 80.00% of your transactions generating a profit, with an average return of +11.36% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
NIOX Analyst Recommendation Trends
Rating
Jan 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
0
0
0
0
0
Buy
5
4
6
4
3
Hold
0
0
0
2
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
4
6
6
6
Each month's total comprises the sum of three months' worth of ratings.
NIOX Stock Forecast FAQ
What is GB:NIOX’s average 12-month price target, according to analysts?
Based on analyst ratings, Circassia Pharmaceuticals’s 12-month average price target is 90.00.
What is GB:NIOX’s upside potential, based on the analysts’ average price target?
Circassia Pharmaceuticals has 26.76% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Circassia Pharmaceuticals a Buy, Sell or Hold?
Circassia Pharmaceuticals has a consensus rating of Moderate Buy, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Circassia Pharmaceuticals’s share price target?
The average share price target for Circassia Pharmaceuticals is 90.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is 90.00p ,and the lowest forecast is 90.00p. The average share price target represents 26.76% Increase from the current price of 71p.
The highest analyst share price target is 90.00p ,and the lowest forecast is 90.00p. The average share price target represents 26.76% Increase from the current price of 71p.
What do analysts say about Circassia Pharmaceuticals?
Circassia Pharmaceuticals’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of Circassia Pharmaceuticals?
To buy shares of GB:NIOX, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.